Description
Phil Newman’s presentation at ADOPTAI 2025 will unveil “Decoding Longevity Trends,” highlighting how advanced data platforms
are transforming investment, R&D, and partnership strategies in the rapidly evolving longevity biotech sector. Attendees will gain insights into the latest longevity market segmentation, the economic impact of healthy lifespan extension, and the rise of
therapies like GLP-1 agonists as possible first-in-class “longevity drugs”. Key topics will include how Newman’s Longevity.Technology platform leverages automated data systems and AI to track biotech innovation aligned with the Hallmarks of Aging, enabling the identification and benchmarking of promising assets, repurposing opportunities, and emerging therapeutics. The session will also cover collaboration
opportunities for investors, executives, and pharmaceutical partners as the field advances from managing aging diseases to developing therapies with the potential to reverse or prevent the processes underlying human aging itself. Participants will leave equipped to navigate—and capitalize on—the convergence of data, science, and industry that is redefining the future of longevity biotech on a global scale.
